Signal active
Contact Information
Social
Primary Organization
2017
2
0
1
251-500
Information Technology, Biotechnology, Alternative Medicine
Bio
Mitchell H. Finer Ph.D. (Mitch) joined MPM Capital as Managing Director in 2015 and is a member of the board of directors of MPM portfolio company Semma Therapeutics. For three decades Mitch has focused in the areas of regenerative medicine, cancer immunotherapy and cell and gene therapy, helping to advance products from conception through phase III clinical programs. Prior to MPM, Mitch served as CSO of bluebird bio, where he was responsible for strategic build of bluebird’s gene therapy business and led the strategic development of the LentiGlobin product from preclinical research through demonstration of long-term therapeutic benefit and safety in beta-thalassemia patients. Mitch continues to serve on bluebird bio’s scientific advisory board.
Prior to bluebird, Mitch has served as CEO of Intracel Corporation and Genteric Inc, and as VP Research for Cell Genesys and the Gencell division of Aventis Pharma (now Sanofi). Mitch also successfully co-founded retinal disease gene therapy company Avalanche Biotechnologies.
Mitch received his Ph.D. in Biochemistry and Molecular Biology from Harvard University and a B.S. in Biochemistry and Microbiology from the University of California at Berkeley. He completed a post-doctoral fellowship at the Whitehead Institute for Biomedical Research at MIT.
Location
Cambridge, Massachusetts, United States, North America
Jobs history
3
Life Edit
CEO
2020 - Current
Basecamp Bio
Founder & President
Invalid date - Current
Abata Therapeutics
Board Member
Invalid date - Current
Educations
2
Harvard University
Biochemistry and Molecular Biology
University of California Berkeley
Biochemistry and Microbiology
Profile Resume
Mitchell Finer is the Chief Scientific Officer at ElevateBio, based in United States, North America. With a background in Information Technology, Mitchell Finer has a rich history of leadership and innovation.Mitchell Finer studied Ph.D Biochemistry and Molecular Biology at Harvard University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.